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ABSTRACT
Objective: The metabolic disorder, Type 2 diabetes mellitus (T2DM), is a major health problem which is the risk factor for the development of 
cardiovascular disease, cerebrovascular accident, renal failure, and other macrovascular diseases. Inflammation is the major pathogenesis of all the 
above conditions. Therefore, there is a need to assess the inflammatory status using simple and reliable marker which would help to diagnose the 
disease and assess the prognosis of the disease. Hence, the aim of the current study is to estimate the level of simple inflammatory marker, C-reactive 
protein (CRP) in Type 2 diabetes individual.
Materials and Method: Fifty patients, reporting to Saveetha Dental College and Hospitals, were enrolled in the study which includes 25 patients 
with T2DM and 25 healthy individuals. 5 ml of venous blood was collected and centrifuged. Then, it is analyzed for fasting blood sugar (FBS), glycated 
hemoglobin (HbA1c), and CRP using the standard kit method. The data obtained were subjected to statistical analysis using the SPSS software.
Results: The mean FBS, HbA1c, and CRP levels were higher in T2DM patients in comparison to healthy individuals. The serum FBS, HbA1c, and CRP 
levels in the control group and T2DM group were 85.08±8.47, 4.27±0.63, and 6.51±0.83 and 168, 7.38±0.9, and 27.23±19.06, respectively. There was 
a significant (p=0.000) difference in the mean CRP levels of the above groups.
Conclusion: CRP level were consistently higher in T2DM individuals; hence, it could be a simple and reliable marker to assess the inflammatory status 
of the diabetic individuals.
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INTRODUCTION
India has the distinction of having the highest number of type 2 diabetes 
mellitus (T2DM) individuals worldwide, with the prevalence of 11.6% 
in the urban population [1,2]. Furthermore, Asian Indians are known 
to be at a high risk for T2DM, cardiovascular disease, and metabolic 
syndrome [3]. In Chennai city, the prevalence had increased from 
5.2% in 1984 to 14.3% in 2003 was reported [4]. The Indian Council 
of Medical Research India Diabetes Study showed that India had 62.4 
million people with diabetes in 2011. This may increase to 101.2 million 
by 2030 [5]. Even though there is the development of high medical and 
diagnostic facilities, many studies show that diabetes is highly prevalent 
in the rural population. Among them newly diagnosed diabetes is high. 
Such persons are at the risk of development of complications [6].
DM is a metabolic disorder characterized by the presence of chronic 
hyperglycemia, insulin resistance, impaired regulation of hepatic 
glucose production, and declining beta cell function eventually 
leading to beta cell failure [7]. Inflammation plays a major role in the 
development of many systemic diseases such as DM, hypertension, 
cardiovascular disease, and cerebrovascular accidents. Diabetes 
itself is risk factors for the development of many other diseases such 
as cardiovascular disease, stroke, renal failure, and other micro and 
macrovascular diseases [8]. There are many inflammatory markers. 
One of the inflammatory markers is C-reactive protein (CRP), which is 
an acute-phase reactant produced by the liver and it is an extremely 
sensitive marker of systemic inflammation and also powerful predictor 
of cardiovascular disease [9-11]. CRP and acute phase-response were 
first discovered in 1930, as precipitation was observed with addition of 
pneumococcal C-polysaccharide to serum of a patient with pneumonia 
[12]. Synthesis of CRP is regulated primarily by interleukin-1, 
interleukin-6, and tumor necrosis factor-α. These proinflammatory 
cytokines are related closely to the impaired glucose metabolism and 
insulin resistance [13]. Glucose metabolism and insulin resistance are 
the key features and major cause of development of DM. CRP is even 
more relevant in Asian Indians who are at high risk for the development 
of insulin resistance, T2DM, and coronary heart disease [14].
Hence, estimation of the level of serum CRP in DM individual is useful 
in clinical practice to diagnose the severity and prognosis of the disease 
condition and select the appropriate therapeutic option.
MATERIALS AND METHODS
Patients were selected from those attending the outpatient Department 
of Saveetha Dental College and Hospitals and divided into two groups 
as follows
 Group I - Normal healthy individuals – 25 individuals.
 Group II - Patients with T2DM – 25 individuals.
Inclusion criteria
• Individuals with the age group of 35–55 years.
• Individuals with T2DM.
Exclusion criteria
• Individuals with other systemic illness such as cardiovascular 
disease, renal failure, stroke, and endocrine illness.
• Individuals with acute illness like fever.
• Immunocompromised individuals
Sample collection
Informed consent was obtained from the patient before sample 
collection. 5 ml of venous blood was collected. 3 ml was distributed 
in plain collection tubes and centrifuged at 3000 rpm for serum. 
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Then, serum was separated and analyzed to estimate the fasting 
blood sugar (FBS) by Trinder’s method and CRP by Turbilatex 
method using ERBA CHEM 5 semi-auto analyzer. Then, 2 ml of blood 
was distributed in EDTA collection tubes and estimated glycated 
hemoglobin (HbA1c) by particle enhanced immunoturbidimetric 
method.
RESULTS
All the data were analyzed using SPSS package. Paired sample t-test 
analysis was done to find out significant differences between the two 
groups. All the tests were considered significant at p<0.05 level.
DISCUSSION
The results of this study revealed that there is a significant difference 
in mean FBS, HbA1c, and CRP levels of the normal individual group and 
T2DM individual group.
Mean serum FBS level in male and female of the T2DM group is 
168.53±35.03 and 146.58±32.8 mg/dl, respectively (Table 1 and 
Fig. 1). Mean blood HbA1c level in male and female of the T2DM group 
is 7.78±0.97 and 6.94±0.59, respectively (Table 1 and Fig. 2). Mean 
serum CRP level in male and female of the T2DM group is 28.85±17.7 
and 25.45±21.09 mg/L, respectively (Table 1 and Fig. 3). All three 
parameters were high in males when compared to the females in T2DM 
individual group.
Mean serum FBS level in male and female of the control group is 
89.23±9.31and 80.58±5.08 mg/dl, respectively (Table 1 and Fig. 1). 
Mean blood HbA1c level in male and female of the control group is 
4.18±0.62 and 4.36±0.68, respectively (Table 1 and Fig. 2). Mean serum 
CRP level in male and female of the control group is 6.39±1.01 and 
6.64±0.64 mg/L, respectively (Table 1 and Fig. 3).
The serum FBS, HbA1c, and CRP levels in the control group and T2DM 
group were 85.08±8.47, 4.27±0.63, and 6.51±0.83 and 168, 7.38±0.9, 
and 27.23±19.06, respectively (Table 2 and Fig. 4). There was a 
significant (p=0.000) difference in the mean CRP levels of the above 
groups.
Our results provide evidence for a positive association between 
CRP levels and T2DM individuals. T2DM is characterized by 
insulin insensitivity as a result of insulin resistance, reduced 
insulin production, and beta cell failure. This leads to decreased 
glucose transport into the liver, muscle cells, and fat cells. There 
is an increase in the breakdown of fat with hyperglycemia [15,16]. 
Hyperglycemia is the key feature of diabetes. This increased blood 
glucose level stimulates the release of inflammatory cytokines 
tumor necrosis factor-α, interleukin-6 from adipocytes, which in 
turn stimulate CRP production in hepatocytes and induce a chronic 
inflammatory state [17,18].
CRP enhances the generation of free radicals by activating the 
complement platelet-activating factors and cytokines which stimulate 
leukocytes and release oxygen radicals or CRP directly stimulates 
monocytes and neutrophils and generates oxygen free radicals [19]. CRP 
and oxygen free radicals induce the expression of adhesion molecules 
in endothelial cells. These molecules are involved in atherogenesis [20]. 
Many studies show that CRP itself plays a role in pathogenesis of T2DM 
and atherosclerosis [21,22].
Hence, by estimating the CRP level, we can evaluate the inflammatory 
status of the diabetic individual, which helps to assess the progression 
of the disease condition.
Table 1: FBS, HbA1c, and CRP levels in male and female of two groups
Parameters Male p value Female p value
Control DM Control DM
FBS 89.23±9.31 168.53±35.03 0.000 80.58±5.08 146.58±32.8 0.000
HbA1C 4.18±0.62 7.78±0.97 0.000 4.36±0.68 6.94±0.59 0.000
CRP 6.39±1.01 28.85±17.7 0.011 6.64±0.64 25.47±21.09 0.001
FBS: Fasting blood sugar, HbA1C: Glycated hemoglobin, CRP: C-reactive protein
Table 2: Mean FBS, HbA1c, and CRP levels in two groups
Parameters Control DM p value
FBS 85.08±8.47 158±35.12 0.000
HbA1C 4.27±0.63 7.38±0.90 0.000
CRP 6.51±0.83 27.23±19.06 0.000
FBS: Fasting blood sugar, HbA1C: Glycated hemoglobin, CRP: C-reactive protein
Fig. 1: Mean fasting blood sugar levels in male and female of two 
groups
Fig. 2: Mean glycated hemoglobin levels in male and female of two 
groups
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CONCLUSION
The present study CRP level was consistently higher in T2DM 
individuals; hence, it could be a simple and reliable marker to assess 
the inflammatory status of the diabetic individuals. Our data suggest 
that the measure of CRP might provide a simple method for the early 
detection of T2DM and its complications.
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Fig. 3: Mean C-reactive protein levels in male and female of two 
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